billHR9599Event Monday, July 6, 2026Analyzed

To strengthen the 340B drug discount program.

Bearish

Summary

HR9599, introduced 2026-07-06, aims to strengthen the 340B drug discount program. It is in early committee stage with no funding. Drug manufacturers face potential revenue headwinds from expanded discount requirements, while covered entities (hospitals, clinics) stand to benefit. No related signals detected.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.HR9599 is an early-stage bill with low immediate probability of passage.
  • 2.If passed, it would negatively impact drug manufacturers by reducing net revenue from 340B discounts.
  • 3.Covered entities (hospitals, clinics) would benefit from improved drug pricing.

Market Implications

The bill is currently in early committee stage, so no immediate market reaction is expected. If it gains momentum, drug manufacturers and $LLY would face negative sentiment. Covered entities (hospitals) are not directly represented in the provided SEC data, but $UNH could see minor benefits. No real market data on price movements is available; the impact is structural based on legislative trajectory.

Full Analysis

  1. On July 6, 2026, Rep. Scott Peters (D-CA) introduced HR9599, a bill to strengthen the 340B drug discount program. The bill was referred to the Committees on Energy and Commerce, Ways and Means, and Education and Workforce. It has 4 cosponsors. This is an early-stage procedural action with no immediate market impact.

  2. The bill authorizes no direct funding. Strengthening the 340B program typically involves expanding the definition of covered entities, increasing mandatory discounts, or tightening manufacturer compliance. Actual spending impact would occur only if the bill passes and is implemented, but the authorization itself does not allocate money.

  3. No related signals, procurement, or executive actions were provided. The bill currently stands alone. Investors should monitor for companion legislation in the Senate and markup activity in House committees.

  4. Structural winners include hospitals and community health centers (covered entities) that receive 340B discounts. Losers are drug manufacturers who must provide deeper discounts. Key publicly traded companies exposed include (Johnson & Johnson) and $LLY (Eli Lilly), both with significant pharmaceutical revenue subject to 340B pricing. $UNH (UnitedHealth) may see indirect effects through Optum Rx, but the impact is less direct.

  5. Timeline: The bill is in early committee referral phase. No hearings scheduled. The 119th Congress runs through 2027. Passage probability is low at this stage. Key milestones: committee markup, House vote, Senate introduction, reconciliation.

Intelligence Surface

Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures

Unconfirmed

No confirming evidence found yet from contracts, insider trades, or congressional activity

$$LLY▼ Bearish
Est. $300.0M$1.0B revenue impact

What the bill does

Strengthening the 340B drug discount program likely expands eligibility or deepens mandatory discounts for covered entities, directly increasing the discount obligation on drug manufacturers.

Who must act

Drug manufacturers participating in the 340B program, including Eli Lilly.

What happens

Expanded discount requirements reduce net revenue from drugs sold to covered entities.

Stock impact

Eli Lilly's pharmaceutical revenue ($34.1B total) is exposed to 340B pricing. Strengthened discounts could reduce revenue by an estimated $300M-$1B annually, depending on scope.

Key Legislators

Rep. Peters, Scott H. [D-CA-50]

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderSep 18, 2026

Enhancing Program Integrity and Integrity and Interagency Coordination in the Administration of the H-1B Nonimmigrant Visa Program

This executive order directs the Secretaries of State, Labor, and Homeland Security to coordinate with Commerce, Education, and the SBA when processing H-1B petitions, and requires them to consider whether the employer has engaged in layoffs of similarly situated U.S. workers within the past year. It also orders the Labor Department to review past labor condition applications for potential enforcement actions against sponsoring employers, effectively tightening scrutiny on H-1B usage, especially by outsourcing firms.

proclamationSep 8, 2026

Accelerating Access To Veterans' Benefits And Employment Opportunities

This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.

Exec OrderAug 10, 2026

Delivering Gold Standard Childhood Vaccine Recommendations for Americans

This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →